dr. nowakowski on using patient performance score and age for mcl treatment
Published 7 years ago • 228 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
0:58
dr. nowakowski on biological heterogeneity in newly diagnosed patients with mcl
-
0:50
dr. nowakowski on evolving treatment paradigm of mcl
-
1:19
dr. nowakowski on the potential role of immunotherapy in mcl
-
2:14
dr. nowakowski on next steps with emerging agents in mcl
-
1:36
challenges in the treatment of patients with mcl
-
1:21
dr. goy on approved agents in the treatment landscape of mcl
-
0:59
dr. lacasce discusses the future of mcl treatment
-
2:06
dr. rule on watching and waiting approach for mcl subset
-
0:59
dr. nowakowski on the rationale of the engine trial in dlbcl
-
1:11
dr. martin on patient preferences with mcl treatment
-
0:46
dr. goy on br plus bortezomib for mcl treatment
-
1:17
dr. michael williams on treating subtypes of mcl
-
1:26
dr. miklos on the results of the zuma-2 trial in mcl
-
1:41
rehabilitation - lymphedema and cording
-
1:25
dr. nowakowski on the rationale for reevaluating enzastaurin in dlbcl
-
1:16
dr. shah on excitement with venetoclax in patients with mcl
-
2:17
dr. lossos on treatment approaches in mcl
-
0:57
meet onco-dermatologist jonathan leventhal, md
-
0:51
dr. miklos on alternative options to kte-x19 in mcl, while awaiting fda decision